Literature DB >> 27004476

Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist.

Kinna Thakarar1, Zoe M Weinstein2, Alexander Y Walley2.   

Abstract

The opioid epidemic in the USA continues to worsen. Medical providers are faced with the challenge of addressing complications from opioid use disorders and associated injection drug use. Unsafe injection practices among people who inject drugs (PWID) can lead to several complications requiring acute care encounters in the emergency department and inpatient hospital. Our objective is to provide a narrative review to help medical providers recognise and address key health issues in PWID, who are being released from the emergency department and inpatient hospital. In the midst of rises in overdose deaths and infections such as hepatitis C, we highlight several health issues for PWID, including overdose and infection prevention. We provide a clinical checklist of actions to help guide providers in the care of these complex patients. The clinical checklist includes strategies also applicable to low-resource settings, which may lack addiction treatment options. Our review and clinical checklist highlight key aspects of optimising the health and safety of PWID. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  VIROLOGY

Mesh:

Year:  2016        PMID: 27004476      PMCID: PMC4967553          DOI: 10.1136/postgradmedj-2015-133720

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  87 in total

1.  Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse.

Authors:  Samuel B Ho; Norbert Bräu; Ramsey Cheung; Lin Liu; Courtney Sanchez; Marisa Sklar; Tyler E Phelps; Sonja G Marcus; Michelene M Wasil; Amelia Tisi; Lia Huynh; Shannon K Robinson; Allen L Gifford; Steven M Asch; Erik J Groessl
Journal:  Clin Gastroenterol Hepatol       Date:  2015-02-24       Impact factor: 11.382

Review 2.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

3.  Filtration of crushed tablet suspensions has potential to reduce infection incidence in people who inject drugs.

Authors:  Huei Ng; Rahul P Patel; Raimondo Bruno; Roger Latham; Troy Wanandy; Stuart McLean
Journal:  Drug Alcohol Rev       Date:  2014-09-06

4.  Mandatory use of prescription drug monitoring programs.

Authors:  Rebecca L Haffajee; Anupam B Jena; Scott G Weiner
Journal:  JAMA       Date:  2015-03-03       Impact factor: 56.272

Review 5.  The medical complications of drug abuse.

Authors:  W Chiang; L Goldfrank
Journal:  Med J Aust       Date:  1990-01-15       Impact factor: 7.738

6.  The "black box" of prescription drug diversion.

Authors:  James A Inciardi; Hilary L Surratt; Theodore J Cicero; Steven P Kurtz; Steven S Martin; Mark W Parrino
Journal:  J Addict Dis       Date:  2009-10

7.  Interim methadone treatment: impact on arrests.

Authors:  Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady; Timothy W Kinlock; Michael S Gordon; Sharon M Kelly; Monique E Wilson; Ashraf Ahmed
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

8.  Opioid overdose prevention with intranasal naloxone among people who take methadone.

Authors:  Alexander Y Walley; Maya Doe-Simkins; Emily Quinn; Courtney Pierce; Ziming Xuan; Al Ozonoff
Journal:  J Subst Abuse Treat       Date:  2012-09-12

9.  A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.

Authors:  Michael I Fingerhood; Van L King; Robert K Brooner; Darius A Rastegar
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

10.  Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2012-11-09
View more
  11 in total

1.  A Call to Action: Hospitalists' Role in Addressing Substance Use Disorder.

Authors:  Honora Englander; Kelsey C Priest; Hannah Snyder; Marlene Martin; Susan Calcaterra; Jessica Gregg
Journal:  J Hosp Med       Date:  2019-10-23       Impact factor: 2.960

2.  Six Moments of Infection Prevention in Injection Drug Use: An Educational Toolkit for Clinicians.

Authors:  Leah Harvey; Jacqueline Boudreau; Samantha K Sliwinski; Judith Strymish; Allen L Gifford; Justeen Hyde; Katherine Linsenmeyer; Westyn Branch-Elliman
Journal:  Open Forum Infect Dis       Date:  2022-01-06       Impact factor: 4.423

Review 3.  Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.

Authors:  Kinna Thakarar; Katherine Nenninger; Wollelaw Agmas
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

4.  Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis.

Authors:  Honora Englander; Konrad Dobbertin; Bonnie K Lind; Christina Nicolaidis; Peter Graven; Claire Dorfman; P Todd Korthuis
Journal:  J Gen Intern Med       Date:  2019-12       Impact factor: 5.128

5.  Hospital policies for opioid use disorder treatment: A policy content analysis and environmental scan checklist.

Authors:  Kelsey C Priest; Honora Englander; Dennis McCarty
Journal:  Gen Hosp Psychiatry       Date:  2021-02-22       Impact factor: 3.238

6.  "You're kind of at war with yourself as a nurse": Perspectives of inpatient nurses on treating people who present with a comorbid opioid use disorder.

Authors:  Gabrielle Horner; Jeff Daddona; Deirdre J Burke; Judith Cullinane; Margie Skeer; Alysse G Wurcel
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

7.  Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services.

Authors:  Kinna Thakarar; Kristina E Rokas; F L Lucas; Spencer Powers; Elizabeth Andrews; Christina DeMatteo; Deirdre Mooney; Marcella H Sorg; August Valenti; Mylan Cohen
Journal:  PLoS One       Date:  2019-11-26       Impact factor: 3.240

8.  Making the business case for an addiction medicine consult service: a qualitative analysis.

Authors:  Kelsey C Priest; Dennis McCarty
Journal:  BMC Health Serv Res       Date:  2019-11-08       Impact factor: 2.655

9.  Medications for Opioid use Disorder Associated With Less Against Medical Advice Discharge Among Persons Who Inject Drugs Hospitalized With an Invasive Infection.

Authors:  Nathanial S Nolan; Laura R Marks; Stephen Y Liang; Michael J Durkin
Journal:  J Addict Med       Date:  2021-04-01       Impact factor: 4.647

10.  Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy Agenda.

Authors:  Sandra A Springer; Joshua A Barocas; Alysse Wurcel; Ank Nijhawan; Kinna Thakarar; Ruth Lynfield; Hermione Hurley; Jessica Snowden; Alice Thornton; Carlos Del Rio
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.